Pembrolizumab-induced Eosinophilic Gastrointestinal Disorders

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Internal Medicine 2022/01/15, Vol.61(2), pp.267-269
Hauptverfasser:	Nakamura, Masakatsu, Otsuka, Toshimi, Kumagai, Motona, Arisawa, Tomiyasu
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies, Monoclonal, Humanized - adverse effects Carcinoma, Non-Small-Cell Lung Gastrointestinal Diseases Humans immune checkpoint inhibitor-related eosinophilic gastrointestinal disorders immune-related adverse event Internal medicine Leukocytes (eosinophilic) Lung Neoplasms non-small cell lung cancer Pembrolizumab Pictures in Clinical Medicine secondary hypereosinophilic syndrome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!